The sodium salt of gentisic acid has been used in the treatment of rheumatic fever (Meyer and Ragan, 1948) . It has been reported that the substance is as active therapeutically as sodium salicylate and has the advantage that it produces few, if any, toxic effects even in doses up to 18 g. per day (Camelin, Accoyer, Pellerat, Lafuma, and Coirault, 1949) .
The concentrations of gentisate in plasma and urine have been measured by means of the blue colour given with ferric chloride (Camelin et al., 1949) or by the determination of the optical density at 320 miu (Consden and Stanier, 1951) . In our opinion neither of these methods is suitable for routine estimations; the ferric chloride reaction is too transient for accurate work, and the measurement of the optical density at 320 myx needs an ultra-violet spectrophotometer. We have therefore devised a photometric method of estimation based on the blue colour given by gentisate with the Folin-Ciocalteu phenol reagent in alkaline solution (Smith, 1950) .
Method
Gentisic acid is quantitatively extracted from acidified plasma or urine by ethyl acetate and completely removed from the organic solvent by 1 % w/ v sodium bicarbonate solution at pH 8.5. The alkalinity of the final extraction medium is a critical factor because gentisic acid is unstable above pH 9.0, being converted to coloured oxidation products. A stronger alkali than 1 % w / v sodium bicarbonate solution completely extracts the gentisic acid from the ethyl acetate, but also causes decomposition of the substance.
The gentisic acid in the bicarbonate extract is estimated by means of its reaction with an aqueous solution of the Folin-Ciocalteu phenol reagent, which is readily available in most clinical laboratories. A blue colour having an absorption maximum at 660 mis develops on the addition of sodium hydroxide; the colour intensity reaches a maximum after one minute but begins to fade after 20 minutes and is reduced to 90% of the maximum intensity after two hours (Fig. 1) . The absorption density of the coloured solution was found to be proportional to the concentration of sodium gentisate up to 12 mg./100 ml. in the plasma and diluted urine, and the method gave a recovery of 96% of added sodium gentisate from plasma or urine. A calibration curve ( be constructed from a series of solutions of sodium gentisate in distilled water, ranging in concentration from 0 to 12 mg./100 ml. The method of estimation is as follows. To 2 ml. of plasma or 2 ml. of diluted urine (usually 1 to 100 with distilled water) 0.5 ml. of 6N.HCl is added, followed by 10 ml. of ethyl acetate. If concentrations greater than 12 mg. /100 ml. are to be measured then 0.5 or 1 ml. of plasma or diluted urine are made up to 2 ml. with distilled water before the addition of the HCI and ethyl acetate. The mixture is shaken for three minutes and centrifuged for five minutes; S ml. of the ethyl acetate layer are removed and added to 5 ml. of 1 % w/v NaHCO3 solution. The mixture is shaken and centrifuged for five minutes; 4 ml. of the bicarbonate layer are removed and 1 ml. of Folin-Ciocalteu reagent (diluted 1 to 3 with distilled water) is added and mixed. After the addition of 1 ml. of 1.5 N.NaOH the solution is allowed to stand for five minutes and the absorption density measured against distilled water in a photo-electric absorptiometer using a 1-cm. cell and a filter transmitting maximally above 660 mpt. We have used a Hilger Spekker photo-electric absorptiometer and an Ilford spectrum red filter No. 608. Samples of plasma and urine from patients not receiving gentisate or salicylate therapy gave negligible blank values with the procedure described above.
Results
Two women, Case 1, aged 16 years (weight 45 kg.), convalescent from a unilateral pleural effusion, and Case 2, aged 18 years (weight 58 kg.), with an artificial pneumothorax, both confined to bed, were given 12 g. of sodium gentisate per day. Four tablets (0.25 g.) were given every two hours from 6 a.m. to 8 p.m. and 16 (0.25 g.) tablets were given at 10 p.m.; there was no restriction of fluid intake. Blood samples were collected by venepuncture at 9.40 a.m. each day and 24-hour urines were collected from 6 a.m. to 6 a.m. The sodium gentisate was given for seven days, and the plasma concentrations and urinary excretion for the two subjects are given in Table I . A representative sample of the tablets was analysed for its content of sodium gentisate by Smith's (1950) method, and the calculated total intake of the substance in each case was 80.64 g. A single dose of 20 tablets (equivalent to 4.80 g. of sodium gentisate) was taken by a healthy man (weight 67 kg.), and the plasma concentrations and urinary excretion of the drug followed over a period of 24 hours (Fig. 3) . Discussion These results demonstrate that about 90% of administered gentisate was recoverable from the urine, that it was rapidly excreted, and that measurable plasma concentrations of 4 to 8 mg./100 ml. were maintained in the two subjects receiving 12 g. of gentisate per day. The maximum plasma concentration (15.5 mg./100 ml.) after a single dose of 5 g. in a healthy male appeared to be reached after two hours, and 80% of the ingested dose was excreted in the urine within eight hours. These findings are not in agreement with those of Meyer and Ragan (1948) , who reported that only about one-quarter of administered gentisate was recoverable from urine and that none could be detected in the blood; the method of estimation used by these authors was not given. Camelin et al. (1949) reported plasma levels of 7.5 to 10 mg./100 ml. in patients receiving 12 g. of gentisic acid per day in 1 g. doses every two hours, and during the course of the present work a preliminary communication by Consden and Stanier (1951) claimed that plasma levels of between 20 and 30 mg./100 ml. could be maintained by sufficiently high dosages and that about 90% of administered gentisate could be recovered from the urine.
It is realized that the results given above are limited in scope and that many factors such as body weight, fluid intake, urine pH and magnitude, and timing of doses may be of importance in determining the plasma concentration of the drug in any given patient. Summary A method of estimating the concentration of sodium gentisate in plasma and urine is described.
In two subjects receiving 12 g. per day of the substance for seven days, plasma concentrations of 4 to 8 mg./100 ml. were maintained, and about 90% of the administered gentisate was recovered in the urine. When a single dose of 5 g. was given to a healthy male the maximum plasma concentration (15.5 mg./100 ml.) appeared two hours after the dose, and 80% of the drug was recovered in the urine within eight hours.
